Recent news
July 2010
New collaboration will investigate TB drugs as possible treatments for neglected tropical diseases
The Global Alliance for TB Drug Development (TB Alliance) and the Drugs for Neglected Diseases initiative (DNDi) have announced a new license agreement that aims to speed development of treatments for several neglected diseases. Under the agreement, the TB Alliance has granted DNDi rights to develop a class of potential TB compounds that also show promise for treating other neglected diseases, such as Chagas disease, African sleeping sickness, and leishmaniasis. See the links below for more details.
